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DESCRIPTION of CASE
D
uring a control check-up after rectal cancer 
treatment, a 67-year-old woman reported 
experiencing frequent bowel movements. Five years 
before, she was treated for a stage I tumour (T2N0M0), 
located 5 cm from the anal verge. The treatment consisted 
of short-course pelvic radiotherapy (5 × 5 Gy), followed 
by low anterior resection (LAR) with straight colorectal 
anastomosis. No post-operative complications had occurred, 
and a temporary colostomy had been constructed, which 
was reversed after four months. The woman had no previous 
medical history.
On questioning, she reported having suffered from rectal 
urgency symptoms ever since the colostomy was reversed. 
These symptoms were quite acceptable, especially because she 
assumed them to be temporary. However, they became worse 
over time, and urgency developed into involuntary stool 
leakage, requiring her to wear a protective pad constantly. 
Furthermore, she indicated that she experienced urine loss, 
especially during coughing, laughing, or lifting. She stated 
that voiding and defecation were fully normal before her 
treatment for rectal cancer.
Are Incontinence Problems after Rectal Cancer 
Treatment Common?
Faecal incontinence after rectal cancer treatment occurs 
frequently, affecting almost half of patients with normal pre-
operative functioning [1]. Incontinence may range from 
inadvertent gas release to minor soiling or complete escape 
of rectal contents. These symptoms are often described 
as “anterior resection syndrome” [2]. Long-term urinary 
incontinence develops in almost one third of patients, and 
combined urinary and faecal incontinence occurs in 14% of 
patients with normal pre-operative function [3,4]. Figure 1 
shows the incidence of faecal and urinary incontinence five 
years after rectal cancer treatment. Incontinence problems 
lead to avoidance of certain activities, such as long-distance 
travel by car or plane, during which bathroom facilities may 
not be immediately available. Additionally, sexual dysfunction 
is a frequent and distressing complication of rectal cancer 
treatment. Male patients may experience ejaculatory 
problems and impotence. Female patients may suffer from 
dyspareunia and vaginal dryness [5]. The poor functional 
outcome of rectal cancer treatment is a major problem, since 
bowel and urinary dysfunction can have a negative impact 
on a patient’s physical, psychological, social, and emotional 
functioning, as well as the patient’s overall well-being [6]. 
What Could Have Caused Her Incontinence Problems?
Faecal incontinence is usually the result of failure of more 
than one component of the continence mechanism. The 
rectum, the anal sphincters, and the pelvic floor muscles are 
essential in the maintenance of faecal continence [7]. First 
of all, the rectum acts as a reservoir to store stool. A smaller 
neorectum after LAR has a lower capacity, causing a decrease 
in maximum tolerated volumes. Furthermore, the anal canal 
contains a rich network of nerve endings sensitive to pain, 
temperature, and touch, which is used to differentiate solid 
or liquid stool from flatus, and allows for selective passage 
of flatus. Patients with a small neorectum after resection of a 
low-lying tumour, as was the case in the present patient, are 
therefore at increased risk for faecal incontinence. Moreover, 
in this patient’s case, rectal cancer resection was preceded 
by pelvic radiotherapy, which is known to increase the risk of 
faecal incontinence [8]. Radiotherapy diminishes compliance 
of the rectum due to fibrosis, resulting in a reduced reservoir 
function. Radiotherapy-induced fibrosis of the myenteric 
plexus of the internal anal sphincter can prevent adequate 
closure of the anal canal in a resting state. In addition, faecal 
incontinence after rectal cancer treatment has been reported 
to be caused by impaired pelvic floor movement, i.e., a 
disturbed change in anorectal angle due to a dysfunctional 
levator ani muscle [9]. According to the latest anatomical 
insight, the levator ani muscle is not innervated by the 
pudendal nerve, but receives its innervation from a separate 
nerve, which runs on the surface of the pelvic floor (a three-
dimensional reconstruction of the levator ani nerve can 
be obtained online in a recent publication in the Journal of 
Clinical Oncology [4]). During surgical dissection deep within 
the pelvis, especially in the case of a low-lying tumour, this 
nerve might be disrupted [4]. 
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Urinary incontinence after rectal cancer treatment may 
consist of urge, overflow, and/or stress incontinence. Urge 
incontinence may result from a reduced bladder capacity 
due to surgical disruption of the sympathetic nerve supply 
(the hypogastric nerves and the pelvic plexus; Figure 2) [10]. 
Overflow incontinence may be caused by surgical damage to 
the sacral splanchnic nerves, resulting in bladder emptying 
problems (Figure 2). However, the present patient suffered 
from involuntary urine loss during increased abdominal 
pressure, which is a sign of urinary stress incontinence. Stress 
urinary incontinence may result from impaired support to 
the urethra and bladder neck. This support is regulated 
by surrounding structures, the most important being the 
pubourethral-vesical ligaments, the suburethral vaginal 
wall, the levator plate, the pubococcygeus muscles, and 
the connective tissue. These components can compensate 
for each other in case of inappropriate function. In post-
menopausal female patients, many of these structures are 
impaired because their function is influenced by oestrogen 
receptors. Additional changed anatomical relations between 
bladder, urethra, and pelvic floor, and possibly damage to 
the innervation of the levator ani muscles during LAR, would 
further impair the continence mechanism and lead to urinary 
incontinence [11].
What Could Have Caused the Worsening of Symptoms 
Over Time?
Improvement in anorectal function usually occurs over six to 
12 months, which correlates with expansion in the reservoir 
capacity of the neorectum. Post-operative assessment of 
function after one year has shown that many patients achieve 
continence to solid stool, but that control of minor staining, 
flatus, and stool frequency is more variable [12]. However, 
worsening of faecal incontinence over time is typically seen 
in patients treated with pelvic radiotherapy (Figure 3). This 
may be explained by the fact that vascular damage is a long-
term effect of radiotherapy, compromising the endovascular 
cushions filling the 7–8 mm gap within the internal sphincter 
ring, which contribute to continence at rest [13]. Worsening 
of urinary incontinence over time could be due to ageing and 
laxity of the pelvic floor musculature, with concomitant risk 
of increased stress incontinence.
How Could Incontinence Problems Have Been 
Prevented?
First, functional problems after rectal cancer surgery 
might have been prevented by special attention to nerve 
preservation. Despite the fact that the current rectal resection 
technique, described by total mesorectal excision (TME), 
permits preservation of the innervation of the pelvic organs, 
nerve-sparing surgery can be difficult. Differences among 
individuals in the running patterns of the nerves and 
variation in the volumes of nerve fibres in each region of 
the pelvis hamper appropriate identification of structures. 
Especially during excessive peroperative blood loss, nerves are 
at risk due to diathermic coagulation and numerous sutures 
to secure haemostasis. To avoid excessive bleeding and 
accidental nerve disruption during surgery, it is important 
to adhere to the surgical plane and reduce the use of blunt 
dissection. Also, the use of a nerve-stimulating device may 
facilitate preservation of the pelvic autonomic nerves during 
pelvic dissection [14].
It is difficult to prevent radiotherapy-induced bowel 
dysfunction, as radiotherapy is considered an important 
part of rectal cancer treatment, decreasing the risk of 
local recurrence [15,16]. However, treating all rectal 
cancer patients with radiotherapy can result in substantial 
overtreatment. Therefore, it is of great importance to 
identify patients with low risk of local recurrence for whom 
radiotherapy is redundant [16]. Currently, new imaging 
modalities are being developed and molecular biomarkers are 
being identified to predict prognosis, making patient-tailored 
treatment a possibility soon.
doi:10.1371/journal.pmed.0050202.g001
Figure 1. Percentage of Faecal and Urinary Incontinence after Rectal 
Cancer Treatment Reported by Patients without Pre-Operative 
Faecal or Urinary Incontinence Who Participated in the Dutch TME 
Trial [16]
doi:10.1371/journal.pmed.0050202.g002
Figure 2. Anatomical Graph of the Pelvic Floor and the Autonomic 
Nerves
Yellow: hypogastric nerves; green: pelvic splanchnic nerves; red: pelvic 
plexus; blue: levator ani nerve. Adapted from: Lange JF (2002) Surgical 
anatomy of the abdomen. Maarssen (Netherlands): Elsevier. p. 178.PLoS Medicine  |  www.plosmedicine.org 1438 October 2008  |  Volume 5  |  Issue 10  |  e202
An alternative to avoid faecal incontinence after rectal 
cancer treatment is to construct a permanent stoma 
by abdominoperineal resection instead of sphincter 
preservation by LAR. Traditionally, the construction of 
a stoma has been regarded as an unfavourable outcome, 
as the quality of life (QOL) experienced by stoma 
patients is believed to be inferior compared to non-stoma 
patients. However, recent studies have shown that QOL 
after abdominoperineal resection may not be as bad as 
once believed and may be equal to that after LAR [17]. 
Moreover, LAR patients with a low anastomosis have been 
reported to have a worse QOL than stoma patients, due 
to poor functional outcome [18]. Obviously, cultural, 
social, religious, and sociodemographic factors influence 
how patients assess their QOL with a permanent stoma. In 
selected cases, abdominoperineal resection might be a more 
satisfactory option than LAR. 
What Treatment Modalities Are Available?
Standards of management of patients with incontinence 
problems after rectal cancer treatment are still lacking. Many 
treatments are available, but there is not enough evidence 
to support the effectiveness of any of them. First of all, 
conservative measures aimed at symptomatic control (e.g., 
dietary regiments, absorbent pads, and pharmacotherapy 
including hormonal manipulation, constipating agents, and 
enemas) may be tried. Colonic irrigation in the morning in 
order to clean the colon of faeces has been shown to reduce 
symptoms [19]. The present patient was offered colonic 
irrigation. During a control check-up one year later, she 
reported a beneficial effect of colonic irrigation, improving 
the quality of her life. 
Alternatively, there are a number of interventions aimed at 
correcting the underlying cause, including both non-surgical 
and surgical techniques. Non-surgical procedures include 
biofeedback and pelvic floor muscle training. Biofeedback 
therapy, showing patients how to use the pelvic floor muscles 
properly, is often recommended and may consist of rectal 
sensitivity, strength, and coordination training [20]. Pelvic 
floor muscle training improves pelvic floor support. It is 
regarded as the first-line treatment for urinary incontinence 
and used to improve faecal incontinence. Pelvic floor muscle 
training may be of limited use in patients in which the 
innervation of the pelvic floor has been damaged during 
surgery.
If conservative management fails, surgical intervention 
may be considered. First, appropriate assessment should 
be carried out for characterisation of the underlying cause. 
Anorectal physiology can be evaluated with manometry, and 
mechanical damage to the sphincter muscle can be detected 
with endoanal ultrasound. If the sphincter is intact, sacral 
nerve stimulation, in which electrodes are inserted through 
the sacral foramina under general anaesthetic for stimulation 
of the sacral nerves, may be effective for both urinary and 
faecal incontinence. Several studies have shown promising 
results; however, experience with sacral nerve stimulation 
for faecal incontinence following rectal resection is still 
limited [21]. In case of a sphincter muscle defect, an artificial 
bowel sphincter can be constructed. This would not be an 
option in the present case, as severe complications after 
artificial bowel sphincter construction in a radiation-injured 
anorectum have been reported [22]. The construction of a 
colostomy is considered an option when all else has failed, 
but is also associated with a significant rate of complications 
in irradiated patients [23]. Uncertainty remains whether any 
surgical intervention does more good than harm. 
DISCUSSION
Incontinence problems after rectal cancer treatment are 
common and can have a major impact on QOL. Nevertheless, 
this issue often remains undiscussed in clinical practice. 
Patients should be informed pre-operatively about the possible 
development of anorectal and urogenital dysfunction and the 
increased risk in case of a low-lying tumour and radiotherapy. 
The different surgical options, LAR and abdominoperineal 
resection, and their potential outcomes should be discussed 
with the patient, as the individual preference of the patient 
is of great importance in this situation [24]. Education on 
modern stoma care may reduce ill-informed hesitations 
towards a permanent stoma by patients. At present, there is an 
ongoing project concerning the perceived costs and benefits 
of pre-operative radiotherapy in rectal cancer treatment, 
which is investigating to what extent patients and oncologists 
believe that patients should also participate in decision-making 
regarding pre-operative radiotherapy. 
Post-operatively, evaluation of the patient’s functional 
outcome should be standard procedure at every follow-up 
appointment. Patients are not likely to bring up incontinence 
problems themselves, out of shame or because they don’t 
relate it to rectal cancer treatment, especially if incontinence 
problems occur several years after treatment. Available 
therapies, primarily conservative regiments, should be 
proposed if needed. 
Although the exact aetiology of incontinence problems 
after multimodality treatment of rectal cancer is unknown, 
specific technical aspects of the surgical procedure play a 
major role. Special attention to pelvic autonomic nerves, 
sharp dissection, adhering to the surgical plane, and reducing 
the use of blunt dissection may lower the risk of urinary 
and faecal incontinence [4]. Furthermore, to prevent 
overtreatment with radiotherapy, a tailor-made approach 
for every rectal cancer patient that is based on pre-operative
doi:10.1371/journal.pmed.0050202.g003
Figure 3. Incidence of Moderate and Severe Faecal Incontinence 
Reported by Patients Who Participated in the Dutch TME Trial [16] 
and Were Treated with Pre-Operative Radiotherapy
Only patients without pre-operative dysfunction were included in this 
diagram.PLoS Medicine  |  www.plosmedicine.org 1439 October 2008  |  Volume 5  |  Issue 10  |  e202
prediction of the risk for local recurrence seems to be 
favourable. Currently, new imaging modalities are being 
developed, and molecular biomarkers have been identified 
that predict prognosis, making patient-tailored treatment 
possible soon [25,26]. This will reduce the number of patients 
with poor functional outcome after rectal cancer treatment.  
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Key Learning Points
sÈ )NCONTINENCEÈPROBLEMSÈAFTERÈRECTALÈCANCERÈTREATMENTÈAREÈ
common and can have a major impact on QOL.
sÈ 0ATIENTSÈSHOULDÈBEÈINFORMEDÈABOUTÈTHEÈSURGICALÈOPTIONSÈ,!2È
and abdominoperineal resection, and about their potential 
outcomes.
sÈ 3URGICALÈNERVEÈDAMAGEÈMAYÈPLAYÈAÈMAJORÈROLEÈINÈTHEÈ
development of faecal and urinary incontinence, with an 
additional effect of radiotherapy.
sÈ &AECALÈINCONTINENCEÈCANÈWORSENÈOVERÈTIMEÈINÈCASEÈOFÈ
radiotherapy.
sÈ 3EVERALÈNON
SURGICALÈANDÈSURGICALÈTHERAPIESÈFORÈINCONTINENCEÈ
problems are available; conservative therapies should be the 
first line-choice. 